Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study.
Journal article published in 2020 by
Frank Tegtmeier,
Reinhard Schinzel,
Andreas Unterberg,
Harald Willschke,
Erich Schmutzhard,
Ronny Beer,
Diederik Bulters,
Jean-Yves LeFrant,
Peter Andrews,
Antonio Belli,
Javier Ibanez,
Alfonso Lagares,
Michael Mokry,
Charlotte Flüh,
Juan Sahuquillo 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled.